Available evidence has indicated elevated levels of IL-6 related with poor prognosis of COVID-19 patients [28, 29].However, Liu et al. reported that solely monitoring blood levels of IL-6 at early stages of COVID-19, may accurately predict disease severity but not mortality [30]. Here, IL6 is linked to COVID-19.